Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4917 total record number 289 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 334 out of 492
4917 citations found

Ascending parabrachio-thalamo-striatal pathways: potential circuits for integration of gustatory and oral motor functions

Iwai, H;Kuramoto, E;Yamanaka, A;Sonomura, T;Uemura, M;Goto, T;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • EAE Model:

    Our EAE model was designed with reagent concentrations that produce a mild-to-moderate form of EAE, always yielding clinical scores of motor dysfunction below 3 and 4 over the 4 week testing period [34]. All animals in the current study exhibited neither paresis of both hindlimbs nor paralysis of one hindlimb, thus allowing nociceptive paw reflex testing. … MOG was bilaterally injected (150 µg/100 µl s.c.) at the flanks under light isoflurane anesthesia on Days 0 and 6. Pertussis toxin (List Biological Laboratories, Campbell, CA) was injected (200 ng/200 µl, i.p.) on days 0 and 2 to facilitate opening of the blood brain barrier to T cells by histamine-induced vascular leakage and/or the priming of autoreactive T cells [16]. Control mice received CFA and pertussis toxin, but not MOG. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes

Hampton, HR;Bailey, J;Tomura, M;Brink, R;Chtanova, T;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis

Rao, E;Singh, P;Li, Y;Zhang, Y;Chi, YI;Suttles, J;Li, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.

Pan, W;Zhu, S;Dai, D;Liu, Z;Li, D;Li, B;Gagliani, N;Zheng, Y;Tang, Y;Weirauch, MT;Chen, X;Zhu, W;Wang, Y;Chen, B;Qian, Y;Chen, Y;Fang, J;Herbst, R;Richman, L;Jallal, B;Harley, JB;Flavell, RA;Yao, Y;Shen, N;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Common clonal origin of central and resident memory T cells following skin immunization.

Gaide, O;Emerson, RO;Jiang, X;Gulati, N;Nizza, S;Desmarais, C;Robins, H;Krueger, JG;Clark, RA;Kupper, TS;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Antigen challenge to skin:

    … For OVA + CT immunization, mice were immunized epicutaneously as previously described8. Briefly, we used scotch tape (3M) to gently remove the cornified layer of ear skin, and then treated the skin with acetone and cholera toxin adjuvant (List Biological Labs) before administrating chicken ovalbumin + cholera toxin.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Phenotype and function of nasal dendritic cells.

Lee, H;Ruane, D;Law, K;Ho, Y;Garg, A;Rahman, A;Esterhzy, D;Cheong, C;Goljo, E;Sikora, AG;Mucida, D;Chen, BK;Govindraj, S;Breton, G;Mehandru, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Hemopexin in severe inflammation and infection: mouse models and human diseases

Lin, T;Maita, D;Thundivalappil, SR;Riley, FE;Hambsch, J;Van Marter, LJ;Christou, HA;Berra, L;Fagan, S;Christiani, DC;Warren, HS;

Product: LPS from Escherichia coli O55:B5

  • Materials:

    LPS from E. coli O55:B5 was purchased from List Biologicals (Campbell, CA, USA). 

    Endotoxemia:

    Mice were injected via tail vein with 40 g of LPS (2 mg/kg) or 4 mg of purified mouse hemoglobin or both in a volume of 200 l,…

    NOTE:  At the time this paper was written, Product #203 (5mg – LPS from Escherichia coli O55:B5) was utilized.

    Product #203 (5 mg – LPS from Escherichia coli O55:B5) is no longer sold.

    Product #203A (2.5 mg – LPS from Escherichia coli O55:B5) is available for purchase.

Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg

Biswas, M;Sarkar, D;Kumar, SR;Nayak, S;Rogers, GL;Markusic, DM;Liao, G;Terhorst, C;Herzog, RW;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae